Edition:
United Kingdom

Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

8.10USD
6:35pm GMT
Change (% chg)

$0.14 (+1.76%)
Prev Close
$7.96
Open
$8.06
Day's High
$8.16
Day's Low
$7.96
Volume
14,165
Avg. Vol
104,024
52-wk High
$10.25
52-wk Low
$6.03

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 10.64 -0.403
Jun '18 6.22 -0.507
Mar '18 5.27 -0.560
FY 2017 Dec '17 -0.02 -0.751
Sep '17 6.18 -0.602
Jun '17 3.05 -0.603
Mar '17 4.15 -0.556
FY 2016 Dec '16 33.14 0.165
Sep '16 59.05 0.772
Jun '16 5.80 -0.293
Mar '16 8.42 -0.315
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 3.94 6.00 2.00 5.43
Quarter Ending Mar-19 3 5.85 6.80 4.50 4.50
Year Ending Dec-18 6 27.05 32.00 24.12 25.59
Year Ending Dec-19 6 28.87 51.50 18.00 49.41
Earnings (per share)
Quarter Ending Dec-18 5 -0.52 -0.44 -0.58 -0.44
Quarter Ending Mar-19 3 -0.49 -0.42 -0.54 -0.41
Year Ending Dec-18 6 -1.98 -1.87 -2.05 -2.00
Year Ending Dec-19 6 -1.76 -1.37 -2.14 -1.67
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. 31.43 148.17 46.24
P/E Low - Last 5 Yrs. 31.43 47.84 24.59
Beta 1.84 1.08 0.91
Price to Sales (TTM) 8.37 49.58 6.22
Price to Book (MRQ) 4.73 10.17 5.20
Price to Tangible Book (MRQ) 4.75 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions 72.39 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -47.38 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago 211.33 47.89 6.50
Sales - 5 Yr. Growth Rate 92.74 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -106.04 75.90 23.08
EPS (TTM) vs TTM 1 Yr. Ago 73.05 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate 29.22 9.25 14.58

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 10.21 3.44 3.10
LT Debt to Equity (MRQ) 13.05 18.69 11.49
Total Debt to Equity (MRQ) 17.23 31.36 16.03
Interest Coverage (TTM) -32.18 -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -5.56 -- --
EBITD - 5 Yr. Avg -47.70 -109.98 13.16
Operating Margin (TTM) -6.83 -184.99 6.07
Operating Margin - 5 Yr. Avg. -48.96 -126.42 8.47
Pre-Tax Margin (TTM) -14.52 -175.75 7.02
Pre-Tax Margin - 5 Yr. Avg. -49.85 -132.58 8.71
Net Profit Margin (TTM) -14.52 -182.49 3.12
Net Profit Margin - 5 Yr. Avg. -49.85 -136.98 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 782,606 7,649,007 873,056,423
Net Income/Employee (TTM) -113,614 653,334 103,484,349
Receivable Turnover (TTM) 7,645.46 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.44 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -6.46 6.47 11.45
Return on Assets - 5 Yr. Avg. -21.10 5.54 12.50
Return on Investment (TTM) -7.41 9.01 14.96
Return on Investment - 5 Yr. Avg. -26.64 6.87 16.23
Return on Equity (TTM) -12.90 10.15 16.52
Return on Equity - 5 Yr. Avg. -31.17 8.41 17.37
  1 Year 3 Year 5 Year
Sales % 271.30 51.42 92.74
EPS (TTM) % 140.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cytokinetics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 5.44 1.81 99 98
13 Week 21.09 15.20 99 94
26 Week 35.67 25.35 99 98
52 Week 65.78 40.51 99 68
YTD 27.57 12.03 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 73.57%
# of Holders: 177
Total Shares Held: 40,250,547
3 Mo. Net Change: 1,425,641
# New Positions: 17
# Closed Positions: 19
# Increased Positions: 77
# Reduced Positions: 63
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.